General Electric Co,
Fiscal Year 2025 Q2.
In the Management Discussion:
escalated
In the Management Discussion:
de-emphasised
In the Management Discussion:
de-emphasised
In the Management Discussion:
de-emphasised
In the Management Discussion:
reworded
In the Management Discussion:
reworded
View specific filings
2 filing documents, in order.
Management Discussion
escalated §7.0 The current filing introduces detailed discussions regarding global supply chain disruptions, inflation mitigation strategies, and the impact of tariffs on operations, while also announcing a change in terminology for reporting GAAP earnings from "Earnings" to "Net income" starting in the first quarter of 2025. These new disclosures detail investments in U.S. manufacturing and efforts to strengthen material availability and manage cost productivity.
FY 2024 Q4 10-Q Removed
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (MD&A). The consolidated financial statements of GE Aerospace are prepared in conformity with U.S. generally accepted accounting principles (GAAP). Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented in this report are calculated from the underlying numbers in millions. Discussions throughout this MD&A are based on continuing operations unless otherwise noted. The MD&A should be read in conjunction with the Financial Statements and Notes to the consolidated financial statements. In the accompanying analysis of financial information, we sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with GAAP. Certain of these data are considered "non-GAAP financial measures" under SEC rules. See the Non-GAAP Financial Measures section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures.
FY 2025 Q2 10-Q Added
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (MD&A). The consolidated financial statements of GE Aerospace are prepared in conformity with U.S. generally accepted accounting principles (GAAP). Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented in this report are calculated from the underlying numbers in millions. Discussions throughout this MD&A are based on continuing operations unless otherwise noted. The MD&A should be read in conjunction with the Financial Statements and Notes to the consolidated financial statements. In the accompanying analysis of financial information, we sometimes use information derived from consolidated financial data but not presented in our financial statements prepared in accordance with GAAP. Certain of these data are considered "non-GAAP financial measures" under SEC rules. See the Non-GAAP Financial Measures section for the reasons we use these non-GAAP financial measures and the reconciliations to their most directly comparable GAAP financial measures. Beginning in the first quarter of 2025, we changed the terminology used to report our GAAP earnings from "Earnings" to "Net income" and our non-GAAP earnings from "Adjusted earnings" to "Adjusted net income." The change in terminology does not impact the amounts reported in the financial statements. BUSINESS OVERVIEW AND ENVIRONMENT. As a global aerospace company, our worldwide operations can be affected by industrial, economic, and political factors on both a regional and global level. Demand for our equipment and services is demonstrated by our backlog of engine orders and services and growth in our installed base, and tends to follow commercial air travel and freight demand and government funding for defense budgets. We also expect a significant ramp in our delivery of engine units and services for newer product platforms in the years ahead to meet this demand. Refer to the Segment Operations sections for Commercial Engines & Services and Defense & Propulsion Technologies below for additional detail about these dynamics for our commercial and defense businesses, respectively. Global material availability and supplier delivery performance continue to cause disruptions and have impacted our production and delivery of equipment and services to our customers. We are investing in our manufacturing facilities, overhaul facilities and our supply chain to increase production and strengthen yield in order to improve delivery to our customers. We continue to partner with our suppliers to improve material input, and work with our customers to calibrate future production rates. We are leveraging FLIGHT DECK and partnering with suppliers to improve material input and proactively manage the impact of inflationary pressure by driving cost productivity and adjusting the pricing of our products and services. We expect the impact of supply chain constraints and inflation will continue, and we are continuing to take action to mitigate the impacts. We support efforts to revitalize domestic manufacturing and are investing $1 billion in U.S manufacturing this year and hiring 5,000 U.S workers. At the same time, we support promoting free and fair trade that ensures the continued strength of the U.S aerospace industry. As we operate in a highly dynamic tariff environment, we are focused on continuing to deliver our products and services to our customers. Given our global business, tariffs will result in additional cost for us and our suppliers. We are optimizing operations and leveraging existing programs and strategies to reduce the impact from tariffs. Additionally, we are taking measures to control cost and implementing pricing actions to primarily mitigate the remaining impact.
de-emphasised Less: gains (losses), impairments, Insurance, and restructuring & other113 481 Corporate & Other operating profit (cost) (GAAP) shifted significantly from mostly negative values in the prior period to positive figures of $43 and $355 in the current period, while Adjusted Corporate & Other operating costs (Non-GAAP) decreased substantially for the two reported periods.
FY 2024 Q4 10-Q Removed
Adjusted Corporate & Other operating costs (Non-GAAP)(201)(220)(452)(593) Corporate & Other operating profit (cost) (GAAP)$(73)$(1,455)$(252)$3,974 Less: gains (losses), impairments, Insurance, and restructuring & other128 (1,236)201 4,567
FY 2025 Q2 10-Q Added
Adjusted Corporate & Other operating costs (Non-GAAP)(70)(125) Corporate & Other operating profit (cost) (GAAP)$43 $355 Less: gains (losses), impairments, Insurance, and restructuring & other113 481
de-emphasised All other operating activities$(746)$(60) The disclosure shifted from a nine-month reporting period to a three-month reporting period, resulting in several changes: working capital drivers were simplified and now include net unfavorable changes in estimated profitability on long-term service contracts; investing activities detail was narrowed to focus primarily on lower cash paid related to the separation of GE Vernova; and financing activities removed historical events such as the redemption of GE preferred stock.
FY 2024 Q4 10-Q Removed
Other15 6 All other operating activities$(105)$444 2024 3Q FORM 10-Q 10 The cash impacts from changes in working capital was $(0.6) billion, a decrease of $0.9 billion compared to the nine months ended September 30, 2023, due to: current receivables of $(0.6) billion, driven by higher volume partially offset by higher collections, including increased collections from CFM International; inventories, including deferred inventory, of $(0.2) billion, driven by higher material purchases and lower liquidations primarily due to output challenges; current contract assets, contract liabilities and current deferred income were flat, driven by higher revenue recognition, offset by higher billings and net unfavorable changes in estimated profitability; progress collections of $0.2 billion, driven by higher collections; and accounts payable of $(0.2) billion, driven by higher disbursements related to purchases of materials in prior periods partially offset by higher volume. Cash used for investing activities was $0.9 billion in the nine months ended September 30, 2024, an increase of $5.8 billion compared to the nine months ended September 30, 2023, primarily due to: higher cash paid related to net settlements between our continuing operations and businesses in discontinued operations of $3.7 billion, primarily related to the separation of GE Vernova of $2.0 billion in 2024 and lower cash received of $1.1 billion related to the separation of GE HealthCare in 2023 (components of All other investing activities); a decrease in proceeds of $3.0 billion from the disposition of our remaining retained ownership interests in AerCap and Baker Hughes of $4.8 billion in 2023, partially offset by an increase in proceeds of $1.9 billion from GE HealthCare. These increases in cash used were partially offset by lower net purchases of insurance investment securities of $0.5 billion and proceeds from the dispositions of our non-core licensing business and Electric Insurance Company of $0.5 billion. Cash used for additions to property, plant and equipment and internal-use software, which are components of free cash flows*, was $0.8 billion and $0.6 billion in the nine months ended September 30, 2024 and 2023, respectively. Cash used for financing activities was $4.5 billion in the nine months ended September 30, 2024, a decrease of $5.7 billion compared to the nine months ended September 30, 2023, primarily due to: cash paid for redemption of GE preferred stock of $5.8 billion in 2023; lower net debt maturities of $2.5 billion; and an increase in cash received of $1.1 billion from stock option exercises (a component of All other financing activities); partially offset by an increase in treasury stock repurchases of $3.2 billion and higher dividends paid to shareholders of $0.2 billion.
FY 2025 Q2 10-Q Added
Other(185)(64) All other operating activities$(746)$(60) The cash impact from changes in working capital was $0.1 billion for the three months ended March 31, 2025, a decrease of $0.2 billion compared to 2024, due to: current receivables of $(0.6) billion, driven by higher volume partially offset by higher collections; inventories, including deferred inventory, of $(0.2) billion, driven by higher material purchases; current contract assets, contract liabilities and current deferred income of $0.1 billion, driven by net unfavorable changes in estimated profitability on long-term service contracts; and accounts payable of $0.5 billion, driven by higher volume, partially offset by higher disbursements related to purchases of materials in prior periods. Cash used for investing activities was $(0.3) billion for the three months ended March 31, 2025, a decrease of $0.8 billion compared to 2024, primarily due to: lower cash paid related to net settlements between continuing operations and businesses in discontinued operations of $2.2 billion, primarily related to the separation of GE Vernova in 2024 (a component of All other investing activities); and lower net purchases of insurance investment securities of $1.2 billion; partially offset by a decrease in proceeds of $2.6 billion from the disposition of our retained ownership interests in GE HealthCare in 2024. Cash used for additions to property, plant and equipment and internal-use software, which are components of free cash flow*, was $(0.2) billion for both the three months ended March 31, 2025 and 2024, respectively. Cash used for financing activities was $(2.3) billion for the three months ended March 31, 2025, an increase of $2.2 billion compared to 2024, primarily due to: an increase in treasury stock repurchases of $1.6 billion; a decrease in cash received of $0.4 billion from stock option exercises (a component of All other financing activities); and higher dividends paid to shareholders of $0.2 billion; partially offset by lower net debt maturities of $0.2 billion.
de-emphasised ADJUSTED NET INCOME (LOSS) AND ADJUSTED EFFECTIVE INCOME TAX RATE (NON-GAAP)Three months ended March 31 The non-GAAP measure was changed from Adjusted Earnings (Loss) to Adjusted Net Income (Loss), and the reporting period shifted from nine months ended September 30 to three months ended March 31.
FY 2024 Q4 10-Q Removed
*Non-GAAP Financial Measure 2024 3Q FORM 10-Q 13 ADJUSTED EARNINGS (LOSS) AND ADJUSTED EFFECTIVE INCOME TAX RATE (NON-GAAP)Three months ended September 30Nine months ended September 30
FY 2025 Q2 10-Q Added
*Non-GAAP Financial Measure 2025 1Q FORM 10-Q 11 ADJUSTED NET INCOME (LOSS) AND ADJUSTED EFFECTIVE INCOME TAX RATE (NON-GAAP)Three months ended March 31
reworded OTHER CONSOLIDATED INFORMATION Interest and other financial charges decreased substantially from $0.8 billion to $0.3 billion for the nine months ended September 30, 2024; additionally, restructuring costs are now reported solely under "Restructuring and other charges for Corporate" instead of "Corporate & Other."
FY 2024 Q4 10-Q Removed
OTHER CONSOLIDATED INFORMATION RESTRUCTURING AND SEPARATION COSTS. Significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other. In addition, we incur costs associated with separation activities, which are also excluded from measurement of segment operating performance for internal and external purposes. See Note 19 for further information on restructuring and separation costs. INTEREST AND OTHER FINANCIAL CHARGES were $0.3 billion for both the three months and $0.8 billion for both the nine months ended September 30, 2024 and 2023, respectively. The primary components of interest and other financial charges are interest on short- and long-term borrowings.
FY 2025 Q2 10-Q Added
OTHER CONSOLIDATED INFORMATION RESTRUCTURING AND SEPARATION COSTS. Significant, higher-cost restructuring programs, primarily related to the separations, are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. In addition, we incur costs associated with separation activities, which are also excluded from measurement of segment operating performance for internal and external purposes. See Note 19 for further information on restructuring and separation costs. INTEREST AND OTHER FINANCIAL CHARGES were $0.2 billion and $0.3 billion for both the three months ended March 31, 2025 and 2024, respectively. The primary components of interest and other financial charges are interest on short- and long-term borrowings.
reworded STATEMENT OF CASH FLOWS The reporting period shortened from nine months to three months, resulting in a decrease in Cash from Operating Activities from $4.5 billion to $1.5 billion. Additionally, the net income adjustments for non-cash losses related to retained and sold ownership interests were narrowed, specifically removing references to AerCap and Baker Hughes.
FY 2024 Q4 10-Q Removed
STATEMENT OF CASH FLOWS CASH FLOWS FROM CONTINUING OPERATIONS. The most significant source of cash in CFOA is customer-related activities, the largest of which is collecting cash resulting from product or services sales. The most significant operating use of cash is to pay our suppliers, employees, tax authorities and postretirement plans. Cash from operating activities was $4.5 billion in nine months ended September 30, 2024, an increase of $1.1 billion compared to the nine months ended September 30, 2023, primarily due to: an increase in net income (after adjusting for depreciation of property, plant, and equipment, amortization of intangible assets and non-cash (gains) losses related to our retained and sold ownership interests in GE HealthCare, AerCap and Baker Hughes) driven by all segments, a decrease in income tax payments, an increase in sales discounts and allowances, primarily due to higher spare parts shipments, partially offset by working capital growth. The components of All other operating activities included:
FY 2025 Q2 10-Q Added
STATEMENT OF CASH FLOWS CASH FLOWS FROM CONTINUING OPERATIONS. The most significant source of cash in CFOA is customer-related activities, the largest of which is collecting cash resulting from product or services sales. The most significant operating use of cash is to pay our suppliers, employees, tax authorities and postretirement plans. Cash from operating activities was $1.5 billion for the three months ended March 31, 2025, a decrease of $0.1 billion compared to 2024, primarily due to: a decrease in All other operating activities, primarily driven by payments of employee benefit liabilities, an increase in income tax payments and working capital growth, partially offset by an increase in net income (after adjusting for depreciation of property, plant, and equipment, amortization of intangible assets and non-cash (gains) losses related to our retained and sold ownership interests in GE HealthCare) driven by all segments and an increase in sales discounts and allowances. The components of All other operating activities included:
reworded Net restructuring and other charges/(cash expenditures)(16)(41)
FY 2024 Q4 10-Q Removed
Nine months ended September 3020242023 Increase (decrease) in employee benefit liabilities45 328 Net restructuring and other charges/(cash expenditures)283 (24)
FY 2025 Q2 10-Q Added
Three months ended March 3120252024 Increase (decrease) in employee benefit liabilities$(550)$128 Net restructuring and other charges/(cash expenditures)(16)(41)
reworded Other deferred assets12 (31)
FY 2024 Q4 10-Q Removed
(Gains) losses on purchases and sales of business interests(377)107 Net interest and other financial charges/(cash paid)18 (133) Other deferred assets(89)159
FY 2025 Q2 10-Q Added
(Gains) losses on purchases and sales of business interests- (14) Net interest and other financial charges/(cash paid)(8)(38) Other deferred assets12 (31)
reworded (a) See the Corporate & Other and Other Consolidated Information sections for further information.
FY 2024 Q4 10-Q Removed
Effective income tax rate (GAAP)10.5%7.8%10.6%5.6% Adjusted effective income tax rate (Non-GAAP)20.3%19.2%20.4%20.8% (a) See the Corporate & Other and Other Consolidated Information sections for further information.
FY 2025 Q2 10-Q Added
Effective income tax rate (GAAP)12.6%12.3% Adjusted effective income tax rate (Non-GAAP)17.6%20.7% (a) See the Corporate & Other and Other Consolidated Information sections for further information.
reworded Cash flows from operating activities (CFOA) (GAAP)$1,543 $1,629
FY 2024 Q4 10-Q Removed
*Non-GAAP Financial Measure 2024 3Q FORM 10-Q 14 FREE CASH FLOWS (FCF) (NON-GAAP)Nine months ended September 30 20242023 Cash flows from operating activities (CFOA) (GAAP)$4,499 $3,354
FY 2025 Q2 10-Q Added
*Non-GAAP Financial Measure 12 2025 1Q FORM 10-Q FREE CASH FLOW (FCF) (NON-GAAP)Three months ended March 31 20252024 Cash flows from operating activities (CFOA) (GAAP)$1,543 $1,629
reworded Less: Corporate & Other restructuring cash expenditures(31)(79)
FY 2024 Q4 10-Q Removed
Add: gross additions to property, plant and equipment and internal-use software(765)(612) Less: separation cash expenditures(716)(617) Less: Corporate & Other restructuring cash expenditures(123)(128)
FY 2025 Q2 10-Q Added
Add: gross additions to property, plant and equipment and internal-use software(208)(204) Less: separation cash expenditures(76)(165) Less: Corporate & Other restructuring cash expenditures(31)(79)
reworded Free cash flow (FCF) (Non-GAAP)$1,441 $1,669
FY 2024 Q4 10-Q Removed
Free cash flows (FCF) (Non-GAAP)$4,572 $3,487 We believe investors may find it useful to compare free cash flows* performance without the effects of separation cash expenditures and Corporate & Other restructuring cash expenditures (associated with the separation-related program announced in the fourth quarter of 2022). We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flows. We also use FCF* as a performance metric at the company level for our annual executive incentive plan and performance stock units granted in 2024.
FY 2025 Q2 10-Q Added
Free cash flow (FCF) (Non-GAAP)$1,441 $1,669 We believe investors may find it useful to compare free cash flow* performance without the effects of separation cash expenditures and Corporate & Other restructuring cash expenditures (associated with the separation-related program announced in the fourth quarter of 2022). We believe this measure will better allow management and investors to evaluate the capacity of our operations to generate free cash flow. We also use FCF* as a performance metric at the company level for our annual executive incentive plan and performance stock units granted in 2025.